ALTMAN JEFFREY A bought ATEX

August 4, 2026 · Form 4 insider transaction

ALTMAN JEFFREY A bought 1,598 shares of Anterix Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
1,598
Price
$0.00
Total value
N/A
Role
SecurityCommon Stock, par value $0.0001 per share ("Common Stock")
Transaction codeA: Grant or award
Transaction dateAugust 4, 2026
Filing dateAugust 6, 2026
Shares owned after17,014
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The shares of Common Stock will vest on the earlier of the 2027 Annual Meeting of shareholders and August 4, 2027, subject to the terms of the Restricted Stock Agreement.; Represents securities granted to Jeffrey Altman ("Mr. Altman" or the "Reporting Person") as compensation for his services as a non-employee director on the Issuer's board of directors. Mr. Altman may be deemed to hold the securities reported herein for the benefit of certain funds (the "Owl Creek Funds") to which Owl Creek Asset Management, L.P., a Delaware limited partnership (the "Investment Manager"), serves as investment manager.; Each of the Investment Manager and Mr. Altman disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any.

View the original Form 4 on SEC EDGAR